Fernanda Ludolf Selected Research

Fernanda Ludolf Research Topics

Disease

33	Visceral Leishmaniasis (Kala Azar) 05/2024 - 10/2018
24	Infections 03/2024 - 08/2007
10	Leishmaniasis 12/2023 - 10/2016
4	Coinfection 12/2021 - 01/2020
3	Chagas Disease (American Trypanosomiasis) 05/2024 - 12/2006
2	Leprosy (Hansen's Disease) 05/2024 - 12/2021
2	Tuberculosis (Tuberculoses) 05/2024 - 12/2021
2	COVID-19 01/2023 - 01/2022
2	HIV Infections (HIV Infection) 12/2021 - 11/2021
1	Malaria 05/2024
1	Aspergillosis 05/2024
1	Histoplasmosis 05/2024
1	Edema (Dropsy) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Paracoccidioidomycosis (South American Blastomycosis) 12/2021
1	Parasitic Diseases (Parasitic Disease) 02/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Rupture 09/2018
1	Necrosis 09/2018
1	Schistosomiasis (Bilharziasis) 01/2016
1	Schistosomiasis mansoni 09/2014
1	Leukemia 09/2014
1	Reinfection 09/2014
1	Sarcoma (Soft Tissue Sarcoma) 08/2007

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 05/2024 - 08/2007
12	VaccinesIBA 01/2023 - 03/2014
10	MicellesIBA 03/2024 - 10/2016
9	AntigensIBA 05/2024 - 03/2014
8	Recombinant ProteinsIBA 05/2024 - 01/2020
5	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 05/2024 - 03/2020
5	AntibodiesIBA 01/2023 - 02/2021
4	Recombinant Fusion ProteinsIBA 05/2024 - 10/2018
4	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2024 - 10/2016
3	Peptides (Polypeptides)IBA 05/2024 - 11/2021
3	vanillinIBA 03/2024 - 08/2023
3	SaponinsIBA 12/2023 - 02/2021
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 10/2018
3	Interleukin-12 (IL 12)IBA 01/2023 - 10/2018
3	Pyridoxal KinaseIBA 12/2020 - 01/2020
3	ProteomeIBA 01/2019 - 03/2014
2	Ivermectin (Mectizan)FDA Link 01/2023 - 02/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 02/2021
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2022 - 10/2018
2	NaphthoquinonesIBA 02/2022 - 01/2019
2	Poloxamer (Poloxamer 407)IBA 01/2022 - 10/2016
2	A-Form DNA (A-DNA)IBA 02/2021 - 01/2019
2	CardenolidesIBA 01/2021 - 01/2021
2	DNA VaccinesIBA 12/2020 - 01/2020
2	Clioquinol (Vioform)FDA Link 01/2020 - 09/2018
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2017 - 01/2016
1	monophosphoryl lipid AIBA 10/2023
1	EndonucleasesIBA 01/2023
1	NitritesIBA 01/2023
1	CytokinesIBA 01/2023
1	EnzymesIBA 06/2022
1	ImmunosorbentsIBA 06/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	N 30IBA 12/2021
1	EpitopesIBA 11/2021
1	Acarbose FDA LinkGeneric 06/2021
1	Virulence Factors (Pathogenicity Factors)IBA 02/2021
1	DigitoxigeninIBA 01/2021
1	miltefosine (Impavido)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Digitoxin FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	UCON 50-HB-5100 (F127)IBA 01/2020
1	Liposomes (Liposome)IBA 11/2018
1	InterferonsIBA 10/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	PolyproteinsIBA 01/2016
1	Subunit VaccinesIBA 01/2016
1	Immunoglobulin E (IgE)IBA 09/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2007
1	Messenger RNA (mRNA)IBA 08/2007
1	Glycoproteins (Glycoprotein)IBA 12/2006

Therapy/Procedure

3	Immunotherapy 05/2024 - 06/2023
2	Therapeutics 02/2022 - 12/2019